Cystic fibrosis (CF) is an autosomal recessive disorder that occurs in ϳ1 in 2500 Caucasians (1) (2) (3) . CF can result from combinations of Ͼ750 known mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, and in certain populations, as many as 1 person in 25 is a carrier (1) (2) (3) . To date, screening methods have either been narrow, requiring multiple methodologies to be brought to bear for comprehensive coverage, or are cost prohibitive (1, 4 ) . This study describes the Luminex LabMAP TM system and its potential for simultaneous, rapid, sensitive, and specific screening for mutations in the CFTR gene.
The LabMAP system incorporates polystyrene microspheres that are internally dyed with two spectrally distinct fluorochromes. Using precise ratios of these fluorochromes, an array is created consisting of 100 different microsphere sets with specific spectral addresses. Each microsphere set can possess a different reactant on its surface. Because microsphere sets can be distinguished by their spectral addresses, they can be combined, allowing up to 100 different analytes to be measured simultaneously in a single reaction vessel. A third fluorochrome coupled to a reporter molecule quantifies the biomolecular interaction that has occurred at the microsphere surface. Microspheres are interrogated individually in a rapidly flowing fluid stream as they pass by two separate lasers in the Luminex 100 analyzer. High-speed digital signal processing classifies the microsphere based on its spectral address and quantifies the reaction on the surface in a few seconds per sample. To evaluate the utility of this platform for CF screening, we constructed a multiplexed assay to detect wild-type and mutant DNA sequences in the CFTR gene. The selected mutations consisted of both single-base changes and small deletions, and are the five most common CF mutations found in North America: ⌬F508 (66.1%), W1282X (2.35%), G542X (2.24%), 621ϩ1G3 T (1.48%), and N1303K (1.25%) (1 ) .
A panel of patient DNA samples characterized for mutations in the CFTR gene was obtained from Coriell Cell Repositories for use in this study. Presumed wildtype genomic DNA samples were obtained from Sigma Chemical Company. Regions of exon 10 (upstream primer 5Ј to 3Ј, TCTGTTCTCAGTTTTCCTGG; downstream primer 5Ј to 3Ј, TTGGCATGCTTTGATGACGC), exon 11 (TAGGACATCTCCAAGTTTGC and CAATAATTAGT-TATTCACCTTGC), exon 20 (GAGACTACTGAACACT-GAAG and TTCTGGCTAAGTCCTTTTGC), exon 21 (TGCTATAGAAAGTATTTATTTTTTCTGG and AGC-CTTACCTCATCTGCAAC), and intron 4 (CTTCATCA-CATTGGAATGCAG and ACTTGTACCAGCTCAC-TACC) containing the mutation sites were amplified by multiplexed PCR to yield amplicons 106 -147 bp in length. Each of the upstream primers was labeled at the 5Ј terminus with biotin. Targets were amplified in 50-L reactions containing 1ϫ PCR buffer (Qiagen), 200 mol/L each dNTP, 0.2 mol/L each primer (Sigma Genosys), 1.5 mmol/L MgCl 2 , 2.5 U of HotStarTaq DNA polymerase (Qiagen), and 100 ng of template DNA. PCR reactions were incubated at 95°C for 15 min to activate the enzyme and then cycled for 40 cycles with denaturation at 94°C for 30 s, annealing at 50°C for 1 min, and extension at 72°C for 1 min. Final extension was done at 72°C for 7 min, and reactions were soaked at 4°C.
Capture oligonucleotide probes specific for each wildtype and mutant sequence [⌬F508 (wild-type 5Ј to 3Ј, AACACCAAAGATGATATTTT; mutant 5Ј to 3Ј, GAAA-CACCAATGATATTTTC), W1282X (GGCTTTCCTC-CACTGTTGCA and GGCTTTCCTTCACTGTTGCA), G542X (CACCTTCTCCAAGAACTATA and CACCT-TCTCAAAGAACTATA), 621ϩ1G3 T (GAAGTATTAC-CTTCTTATAA and GAAGTATTAACTTCTTATAA), and N1303K (GGGATCCAAGTTTTTTCTAA and GGGATC-CAACTTTTTTCTAA)] were synthesized with a 5Ј amine Uni-Link modification (Oligos Etc). Probes were 20 nucleotides in length, complementary in sequence to the biotinylated strand of the amplicon, and designed with the specific wild-type or mutant nucleotide(s) centered within the probe sequence. Probes were coupled to carboxylated microspheres using a previously described carbodiimide coupling method (5 ) . Briefly, for each probe and microsphere set combination, 5 ϫ 10 6 carboxylated microspheres were suspended in 50 L of 0.1 mol/L MES, pH 4.5. One nmol of amine-substituted probe oligonucleotide was added, followed by the addition of 25 g of N-(3dimethylaminopropyl)-NЈ-ethylcarbodiimide (EDC) and incubation in the dark for 30 min. The addition of EDC and incubation were repeated, and the microspheres were washed once with 0.2 mL/L Tween 20 and once with 1 g/L sodium dodecyl sulfate. Coupled microspheres were stored in MES containing 1 mmol/L EDTA, pH 8.0, at 2-8°C in the dark.
After PCR amplification, 5 L of each reaction was denatured at 95°C for 10 min and added to hybridization solution [3 mol/L tetramethylammonium chloride, 50 mmol/L Tris-HCl (pH 8.0), 4 mmol/L EDTA (pH 8.0), 1 g/L Sarkosyl] containing a mixture of 5000 of each probe-coupled microsphere set in a 50-L total reaction volume. Reactions were hybridized at 55°C for 10 min, pelleted by microcentrifugation, and resuspended in 50 L of hybridization solution. Hybridized amplicons were labeled with 120 ng of streptavidin-R-phycoerythrin (Molecular Probes) at 55°C for 5 min (62 L total reaction volume). Reactions were then analyzed on the Luminex 100 . Assay results were obtained ϳ30 min after amplification.
DNA samples were amplified twice, and two aliquots of each reaction were analyzed in four independent experiments. Typical results are presented in Fig. 1 . The bar graph (Fig. 1, top) indicates the net median fluorescence for each probe-coupled microsphere set for a wild- type DNA sample. The net median fluorescence values obtained for all 15 patient DNA samples are also shown (Fig. 1, bottom) . The Luminex LabMAP simultaneously and correctly identified the genotype of the five selected CFTR mutations in all patient DNA samples tested. Net fluorescence ranged from 121 to 737 above background for all positive alleles. The signal-to-noise ratio for each wild-type and corresponding mutant probe pair was Ն7.2 in all cases.
This study demonstrates the potential of the Luminex LabMAP system for simultaneous, rapid, and specific molecular genetic analyses of multiple nucleic acid targets. Because the LabMAP system is capable of screening a single sample for 100 different analytes simultaneously, probes for up to 50 CFTR mutations (and corresponding wild-type sequences) could be combined in a single reaction well. Screening for additional mutations could be performed in multiple wells, and additional probe-coupled microsphere sets could be included as internal controls for sample integrity and yield.
In summary, this pilot study demonstrates the potential of the Luminex LabMAP system as an analysis platform suitable for routine multiplexed screening for diverse CF mutations. Analysis with the system is rapid, requires relatively few sample manipulations, and produces adequate resolution to reliably genotype five of the most commonly occurring CF mutations.
Rapid and Sensitive Closed-Tube Quantification of Human Interferon-␥ mRNA by Reverse Transcription-PCR
Utilizing Energy-Transfer Labeled Primers, Hiroshi Uehara, * Glenn Nardone, Sandra Randall, Yuri Khripin, and Dan St. Louis (Intergen Discovery Products, 202 Perry Pkwy., Gaithersburg, MD 20877; * author for correspondence: fax 301-963-5017, e-mail h.uehara@intergenco.com) Quantification of cytokine gene expression is essential for understanding the biological roles of cytokines in immune responses. Quantitative reverse transcription-PCR has become popular for the sensitive detection and quantification of mRNA (1 ) . However, the necessity of post-PCR sample processing with the potential for carryover contamination of the amplicon makes it a difficult methodology for routine clinical testing.
Using Amplifluor TM technology, we have developed a rapid and extremely sensitive assay for cytokine mRNA quantification. The high signal-to-noise ratio of the assay that is achieved by the unique structure of Amplifluor primers allows for closed-tube fluorescence detection and quantification during PCR amplification (real time) or at endpoint. Elimination of laborious post-PCR sample processing enables high-throughput analysis and greatly reduces the risk of carryover contamination. The Amplifluor primer system is a molecular switch for detecting DNA amplification by energy transfer between fluorophore and quencher (2, 3 ) . The OFF-to-ON transition occurs when the conformation of the Amplifluor primer changes from "closed" intramolecular stem-loop structure to an "open" extended structure. This structural change is achieved when the Amplifluor primers are incorporated into a double-stranded DNA molecule by primer-medi- (A), each curve corresponds to the calibration curve obtained with different PCR cycles (31, 33, 35, and 37, respectively). The calibration curves show the typical amplification dynamics of the Amplifluor system with the number of PCR cycles performed. (B), thermocycling conditions identical to those described for endpoint analysis were used, and the fluorescence was monitored at the annealing step.
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